XML 69 R61.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Reporting - Summary of Significant Expenses and Other Segment Items (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
May 08, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Segment Reporting [Abstract]                  
Revenues   $ 21,768     $ 18,151     $ 59,744 $ 50,894
Direct costs and expenses (less employee related expenses and depreciation and amortization)   3,061     3,207     8,634 8,296
Employee related expenses (less share-based compensation expenses)   16,933     14,109     48,703 41,014
Contracted services expenses   1,511     1,771     5,691 4,811
Sales and marketing education and event expenses   1,748     1,619     5,601 6,057
Occupancy and equipment service expenses   1,129     975     3,079 3,071
Clinical trials and associated costs   284     268     1,287 912
Depreciation and amortization expense   1,406     1,493     4,283 4,324
Share-based compensation expenses   1,053     1,515     3,064 5,373
Interest expense   2,074     2,041     5,657 6,506
Change in fair value of warrant liability, net $ 200             280  
Other segment items   1,285     1,411     4,750 5,210
Net loss   $ (8,716) $ (11,468) $ (11,101) $ (10,258) $ (10,808) $ (13,614) $ (31,285) $ (34,680)